Inventor · disambiguated record
Surender Kharbanda
Also filed as: KHARBANDA SURENDER
18 granted patents·13 pending applications·25 citations·filing 2002–2022
91Inventor score
Files withDANA FARBER CANCER INST INC10KUFE DONALD W8HILLSTREAM BIOPHARMA INC3GENUS ONCOLOGY LLC2KHARBANDA SURENDER2
Top patents by PatentIndex Score
31 records- 0188US11136410B2Antibodies against the MUC1-C/extracellular domain (MUC1-C/ECD)DANA FARBER CANCER INST INC·Filed 2018·Granted Oct 5, 2021·2 cites·4 claims
- 0285US8524669B2MUC-1 cytoplasmic domain peptides as inhibitors of cancerKUFE DONALD W·Filed 2009·Granted Sep 3, 2013·6 cites·26 claims
- 0383US9546201B2MUC-1 cytoplasmic domain peptides as inhibitors of cancerDANA FARBER CANCER INST INC·Filed 2015·Granted Jan 17, 2017·3 cites·20 claims
- 0479US10059775B2Antibodies against the MUC1-C/extracellular domain (MUC1-C/ECD)DANA FARBER CANCER INST INC·Filed 2015·Granted Aug 28, 2018·2 cites·25 claims
- 0577US12466895B2Antibodies against the MUC1-c/extracellular domain (MUC1-C/ECD)DANA FARBER CANCER INST INC·Filed 2021·Granted Nov 11, 2025·0 cites·29 claims
- 0677US10617773B2Antibodies against the MUC1-C/extracellular domain (MUC1-C/ECD)DANA FARBER CANCER INST INC·Filed 2017·Granted Apr 14, 2020·1 cites·16 claims
- 0777US8685928B2Antagonists of MUC1KUFE DONALD W·Filed 2011·Granted Apr 1, 2014·1 cites·27 claims
- 0877US8614186B2Inhibition of inflammation using antagonists of MUC1KUFE DONALD W·Filed 2010·Granted Dec 24, 2013·3 cites·27 claims
- 0971US9096687B2Inhibition of inflammation using antagonists of MUC1DANA FARBER CANCER INST INC·Filed 2013·Granted Aug 4, 2015·1 cites·40 claims
- 1071US8957185B2MUC-1 cytoplasmic domain peptides as inhibitors of cancerKUFE DONALD W·Filed 2012·Granted Feb 17, 2015·1 cites·15 claims
- 1168US8129506B2Modulation of the interaction of MUC1 with MUC1 ligandsKHARBANDA SURENDER·Filed 2004·Granted Mar 6, 2012·3 cites·14 claims
- 1267US8952054B2Small molecule inhibitors of MUC1 and methods of identifying the sameKUFE DONALD W·Filed 2011·Granted Feb 10, 2015·1 cites·22 claims
- 1367US6900239B2Tumor chemopotentiation using isocoumarin derivativesILEX PRODUCTS INC·Filed 2002·Granted May 31, 2005·1 cites·18 claims
- 1464US9663562B2Compositions and methods for treating cancerDANA FARBER CANCER INST INC·Filed 2014·Granted May 30, 2017·0 cites·20 claims
- 1563US2022175688A1Polymeric nanoparticlesHILLSTREAM BIOPHARMA INC·Filed 2021·Application pending·0 cites
- 1660US2023157969A1POLYMERIC NANOPARTICLES PROVIDING NUCLEIC ACIDS ENCODING TNF-aHILLSTREAM BIOPHARMA INC·Filed 2022·Application pending·0 cites
- 1757US9572855B2Combination anti-estrogen receptor cancer therapy using MUC1 peptides and chemotherapeuticsDANA FARBER CANCER INST INC·Filed 2014·Granted Feb 21, 2017·0 cites·36 claims
- 1857US2023265208A1Antibodies against the muc1-c/extracellular domain (muc1-c/ecd)DANA FARBER CANCER INST INC·Filed 2021·Application pending·0 cites
- 1956US9789156B2Combination anti-human epidermal growth factor receptor 2 (anti-HER2) cancer therapy using mucin 1 (MUC1) peptides and hemotherapeuticsDANA FARBER CANCER INST INC·Filed 2014·Granted Oct 17, 2017·0 cites·41 claims
- 2056US2014322332A1Antagonists of muc1GENUS ONCOLOGY LLC·Filed 2014·Application pending·0 cites
- 2154US2024262930A1Multi-specific antibody constructs against the muc1-c/extracellular domain (muc1-c/ed)XYONE THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2252US2008090770A1Modulation of Muc1 Mediated Signal TransductionBELMARES MICHAEL P·Filed 2004·Application pending·0 cites
- 2351US11484507B2Polymeric nanoparticles providing nucleic acids encoding TNF-αNANOPROTEAGEN·Filed 2017·Granted Nov 1, 2022·0 cites·34 claims
- 2450US2007202134A1Muc1 Antagonist Enhancement of Death Receptor Ligand-Induced ApoptosisKUFE DONALD W·Filed 2005·Application pending·0 cites
- 2547US9044421B2Treating MUC1-expressing cancers with combination therapiesGENUS ONCOLOGY LLC·Filed 2013·Granted Jun 2, 2015·0 cites·15 claims
- 2647US2004018181A1MUC1 interference RNA compositions and methods derived therefromFiled 2003·Application pending·0 cites
- 2747US2019133963A1Polymeric nanoparticlesNANOPROTEAGEN·Filed 2016·Application pending·0 cites
- 2845US2020046648A1Polymeric nanoparticles comprising salinomycinKHARBANDA SURENDER·Filed 2019·Application pending·0 cites
- 2943US2019151340A1Polymeric nanoparticles comprising bortezomibHILLSTREAM BIOPHARMA INC·Filed 2018·Application pending·0 cites
- 3043US2013101664A1Muc1 ligand traps for use in treating cancersKUFE DONALD W·Filed 2012·Application pending·0 cites
- 3143US2013039974A1Anti-muc1 antibodies for cancer diagnosticsKUFE DONALD W·Filed 2012·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Surender Kharbanda files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →